These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11351495)

  • 1. Response of cortical bone to antiresorptive treatment.
    Hyldstrup L; Jørgensen JT; Sørensen TK; Baeksgaard L
    Calcif Tissue Int; 2001 Mar; 68(3):135-9. PubMed ID: 11351495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of bone mineral density by digital X-ray radiogrammetry: theoretical background and clinical testing.
    Rosholm A; Hyldstrup L; Backsgaard L; Grunkin M; Thodberg HH
    Osteoporos Int; 2001; 12(11):961-9. PubMed ID: 11804024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss.
    Hoff M; Haugeberg G; Kvien TK
    Arthritis Res Ther; 2007; 9(4):R81. PubMed ID: 17705865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women.
    Bouxsein ML; Parker RA; Greenspan SL
    Osteoporos Int; 1999; 10(6):505-9. PubMed ID: 10663352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical hand bone porosity and its association with distal radius fracture in middle aged and elderly women.
    Dhainaut A; Hoff M; Syversen U; Haugeberg G
    PLoS One; 2013; 8(7):e68405. PubMed ID: 23844197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone densitometry: a new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment.
    Ravn P; Alexandersen P; Møllgaard A
    Osteoporos Int; 1999; 9(4):277-83. PubMed ID: 10550443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serial bone mineral density testing for osteoporosis.
    Crandall C
    J Womens Health Gend Based Med; 2001 Nov; 10(9):887-95. PubMed ID: 11747684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.
    Greenspan SL; Beck TJ; Resnick NM; Bhattacharya R; Parker RA
    J Bone Miner Res; 2005 Sep; 20(9):1525-32. PubMed ID: 16059624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital radiogrammetry as a new diagnostic tool for estimation of disease-related osteoporosis in rheumatoid arthritis compared with pQCT.
    Böttcher J; Pfeil A; Heinrich B; Lehmann G; Petrovitch A; Hansch A; Heyne JP; Mentzel HJ; Malich A; Hein G; Kaiser WA
    Rheumatol Int; 2005 Aug; 25(6):457-64. PubMed ID: 15761729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
    Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
    Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
    J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital x-ray radiogrammetry identifies women at risk of osteoporotic fracture: results from a prospective study.
    Bach-Mortensen P; Hyldstrup L; Appleyard M; Hindsø K; Gebuhr P; Sonne-Holm S
    Calcif Tissue Int; 2006 Jul; 79(1):1-6. PubMed ID: 16868669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of combination regimens for osteoporosis--prevention and treatment.
    Miller E; Kalin MF
    Int J Fertil Womens Med; 2002; 47(5):198-204. PubMed ID: 12469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital X-ray radiogrammetry and its sensitivity and specificity for the identification of rheumatoid arthritis-related cortical hand bone loss.
    Pfeil A; Haugeberg G; Renz DM; Reinhardt L; Jung C; Franz M; Wolf G; Böttcher J
    J Bone Miner Metab; 2017 Mar; 35(2):192-198. PubMed ID: 26979320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC Study.
    Ravn P; Overgaard K; Huang C; Ross PD; Green D; McClung M
    Osteoporos Int; 1996; 6(4):308-13. PubMed ID: 8883120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of digital X-ray radiogrammetry and peripheral dual energy X-ray absorptiometry in patients attending fracture clinic after distal forearm fracture.
    Reed MR; Murray JR; Abdy SE; Francis RM; McCaskie AW
    Bone; 2004 Apr; 34(4):716-9. PubMed ID: 15050903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.
    Christgau S; Bitsch-Jensen O; Hanover Bjarnason N; Gamwell Henriksen E; Qvist P; Alexandersen P; Bang Henriksen D
    Bone; 2000 May; 26(5):505-11. PubMed ID: 10773591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
    Harris ST; Eriksen EF; Davidson M; Ettinger MP; Moffett AH; Baylink DJ; Crusan CE; Chines AA
    J Clin Endocrinol Metab; 2001 May; 86(5):1890-7. PubMed ID: 11344179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.